Detalhe da pesquisa
1.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
Cell
; 185(21): 3992-4007.e16, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198317
2.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
Cell
; 185(12): 2103-2115.e19, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568035
3.
Structural linkage between ligand discrimination and receptor activation by type I interferons.
Cell
; 146(4): 621-32, 2011 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854986
4.
Harnessing the power of IFN for therapeutic approaches to COVID-19.
J Virol
; 98(5): e0120423, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651899
5.
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
J Virol
; 97(10): e0101123, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796123
6.
Correction: SARS-CoV-2 suppresses IFNß production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
PLoS Pathog
; 17(12): e1010146, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890433
7.
SARS-CoV-2 suppresses IFNß production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
PLoS Pathog
; 17(8): e1009800, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437657
8.
Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case.
Biochemistry
; 60(46): 3429-3435, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196543
9.
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.
PLoS Pathog
; 14(8): e1007246, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142226
10.
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.
Nature
; 511(7511): 601-5, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043006
11.
Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders.
Proc Natl Acad Sci U S A
; 113(52): 14982-14987, 2016 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956635
12.
Selecting for Fast Protein-Protein Association As Demonstrated on a Random TEM1 Yeast Library Binding BLIP.
Biochemistry
; 57(31): 4644-4650, 2018 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29671590
13.
The molecular basis for differential type I interferon signaling.
J Biol Chem
; 292(18): 7285-7294, 2017 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28289098
14.
Quantifying enzyme activity in living cells.
J Biol Chem
; 292(38): 15838-15848, 2017 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784664
15.
The molecular basis for functional plasticity in type I interferon signaling.
Trends Immunol
; 36(3): 139-49, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25687684
16.
Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.
J Biol Chem
; 291(7): 3371-84, 2016 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679999
17.
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNß drugs in the treatment of multiple sclerosis.
Hum Mol Genet
; 24(11): 3192-205, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721402
18.
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.
Immunol Rev
; 250(1): 317-34, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23046138
19.
Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis.
J Biol Chem
; 289(42): 29014-29, 2014 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25193661
20.
Protein-binding dynamics imaged in a living cell.
Proc Natl Acad Sci U S A
; 109(5): 1461-6, 2012 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22307600